nach oben

Child's Nervous System

Erschienen in:

01.06.2003 | Review Paper

Ependymoma

verfasst von: Charles Teo, Peter Nakaji, Patricia Symons, Vivienne Tobias, Richard Cohn, Robert Smee

Erschienen in: Child's Nervous System | Ausgabe 5-6/2003

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The management of a patient with an ependymoma is controversial. Although the necessity for a multi-disciplined approach is accepted, the exact roles for all disciplines are poorly defined.

Review

This review article examines the current status of histopathological and cytogenetic diagnosis, surgical, chemotherapeutic and radiotherapeutic treatment and future directions.

Adams JH, Graham D, Doyle (1981) Brain biopsy. The smear technique for neurosurgical biopsies. Chapman and Hall, London

Akyuz C, Emir S, Akalan N, Soylemezoglu F, Kutluk T, Buyukpamukcu M (2000) Intracranial ependymomas in childhood—a retrospective study of sixty-two children. Acta Oncol 39:97–100

Ang LC, Taylor AR, Bergin D, Kaufmann JCE (1990) An immunohistochemical study of papillary tumours in the central nervous system. Cancer 65:2712–2719PubMed

Asazuma T, Toyama Y, Suzuki N, Fujimura Y, Hirabayshi K (1999) Ependymomas of the spinal cord and cauda equina: an analysis of 26 cases and a review of the literature. Spinal Cord 37:753–759PubMed

Awaad YM, Allen JC, Miller DC, Schneider SJ, Wisoff, Epstein FJ (1996) Deferring adjuvant therapy for totally resected intracranial ependymoma. Pediatr Neurol 14:216–219CrossRefPubMed

Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumours of childhood. N Engl J Med 326:988–993

Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN (1996) Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39:135–140PubMed

Bloom HJ (1979) Recent concepts in the conservative treatment of intracranial tumours in children. Acta Neurochir (Wien) 50:103–116

Bloom HJ (1982) Intracranial tumours: response and resistance to therapeutic endeavors, 1970–1980. Int J Radiat Oncol Biol Phys 8:1083–1113PubMed

10.

Bouffet E, Foreman N (1999) Chemotherapy for intracranial ependymomas [review]. Childs Nerv Syst 15:563–570CrossRefPubMed

11.

Cenacchi G, Morra I, Forni M, Giangaspero F (1999) Mucin-secreting cellular ependymoma: a light and electron microscopy study. Ultrastruct Pathol 23:319–323CrossRefPubMed

12.

Chiu JK, Woo SY, Ater J, Connelly J, Bruner JM, Maor MH, van Eys J, Oswald MJ, Shallenberger R (1992) Intracranial ependymoma in children: analysis of prognostic factors. J Neurooncol 13:283–290PubMed

13.

Chung JY, Lee SK, Yang KH, Song MK (1999) Subcutaneous sacrococcygeal myxopapillary ependymoma. Am J Neuroradiol 20:344–346PubMed

14.

Cushing H (1932) Intracranial tumours. Notes upon a series of two thousand verified cases with surgical-mortality percentages pertaining thereto. Thomas, Springfield

15.

Diedrich U, Eckermann O, Schmidtke J (1988) Rare Ha-ras and c-mos alleles in patients with intracranial tumours. Neurology 38:221–224

16.

Diedrich U, Soja S, Behnke J, Zoll B (1991) Amplification of the c-erb B oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol 238:221–224PubMed

17.

Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, et al (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours [see comments]. N Engl J Med 328:1725–1731

18.

Ernestus RI, Schroder R, Stutzer H, Klug N (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12:522–526PubMed

19.

Ernestus RI, Wilcke O, Schroder R (1991) Supratentorial ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir (Wien) 111:96–102

20.

Ernestus RI, Schroder R, Stutzer H, Klug N (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12:522–526PubMed

21.

Ernestus RI, Schroder R, Stutzer H, Klug N (1997) The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg 11:421–428CrossRefPubMed

22.

Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL (1996) Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. Med Pediatr Oncol 27:8–14CrossRefPubMed

23.

Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet J-C, Lena G, Choux M, Pellissier JF (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93:605–613PubMed

24.

Fink KL, Rushing EJ, Schold SC Jr (1996) Infrequency of p53 gene mutations in ependymomas. J Neurooncol 27:111–115PubMed

25.

Fletjer WL, Li FP, Antman KH, et al (1989) Recurring loss of chromosomes 1, 3, and 22 in malignant mesolthelioma. Possible sites of tumor suppressor genes. Genes Chromosomes Cancer 1:148–154PubMed

26.

Foreman NK, Love S, Thorne R (1996) Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg 24:119–125PubMed

27.

Foreman NK, Love S, Gill SS, Coakham HB (1997) Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report. Neurosurgery 40:856–860PubMed

28.

Friede RL, Pollack A (1978) The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol 37:103–118

29.

Fujimoto M, Sheridan PJ, Sharp ZD, Weaker FJ, Kagan-Hallet S, Story JL (1989) Proto-oncogene analysis in brain tumours. J Neurosurg 70:910–915PubMed

30.

Furness PN, Lowe J, Tarrant GS (1990) Subepithelial basement membrane deposition and intermediate filament expression in choroid plexus neoplasms and ependymomas. Histopathology 16:251–255PubMed

31.

Garcia-Barriola V, De Gomez MN, Suarez JA, Lara C, Gonzalez JE, Garcia-Tamayo J (2000) Ovarian ependymoma. A case report. Pathol Res Pract 196:595–599PubMed

32.

Goldwein LW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L, D'Angio GJ (1990) Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66:557–563PubMed

33.

Griffin CA, Long PP, Carson BS (1992) Chromosome abnormalities in low-grade central nervous system tumours. Cancer Genet Cytogenet 60:67–73CrossRefPubMed

34.

Grill J, Kalifa C, Doz F, Schoepfer C, Sainte-Rose C, Couanet D et al (1996) A high-dose busulfan thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 25:7–12PubMed

35.

Grill J, Le Deley MC, Gambarelli D, Raquin MA, Couanet D, Pierre-Kahn A, Habrand JL, Doz F, Frappaz D, Gentet JC, Edan C, Chastagner P, Kalifa C, French Society of Pediatric Oncology (2001) Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19:1288–1296PubMed

36.

Hamilton RL, Pollack IF (1997) The molecular biology of ependymomas. Brain Pathol 7:807–822PubMed

37.

Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ (1991) The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28:666–671PubMed

38.

Helwig EB, Stern JB (1984) Subcutaneous sacrococcygeal myxopapillary ependymoma: a clinicopathologic study of 32 cases. Am J Clin Pathol 81:156–161PubMed

39.

Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG (2001) Chromosomal abnormalities subdivide ependymal tumours into clinically relevant groups. Am J Pathol 158:1137–1143PubMed

40.

Horn B, Heideman R, Geyer R, et al (1999) A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21:203–211CrossRefPubMed

41.

Johnson JM, Jessurun J, Leonard A (1999) Sacrococcygeal ependymoma: case report and review of the literature. J Pediatr Surg 34:1405–1407PubMed

42.

Kara-Terki R, Gaudin P, Brun F, Juvin R, Pasquier B, Phelip X (2000) Bone metastases from a cerebral and sacral ependymoma. Report of a case. Joint Bone Spine 67:471–474PubMed

43.

Kawano N, Ohba Y, Nagashima K (2000) Eosinophilic inclusions in ependymoma represent microlumina: a light and electron microscopic study. Acta Neuropathol (Berl) 99:214–218

44.

Kimura T, Budka H, Soler F (1986) An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumours. Clin Neuropathol 5:21–27PubMed

45.

Kleihues P, Cavanee W (2000) World Health Organization classification of tumours, pathology and genetics, tumours of the nervous system. Chapter 3: Ependymal tumours. IARC, Lyon

46.

Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. WHO Blue Book, 2nd edn. Springer, Berlin Heidelberg New York

47.

Kline MJ, Kays DW, Rojiani AM (1996) Extradural myxopapillary ependymoma: report of two cases and review of the literature. Pediatr Pathol Lab Med 16:813–822CrossRefPubMed

48.

Kramer DL, Parmiter AH, Rorke LB (1998) Molecular cytogenetic studies of pediatric ependymomas. J Neurooncol 37:25–33CrossRefPubMed

49.

Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Hoppner W, Stavrou D, Fillbrandt R, Westphal M (2001) Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 91:803–808CrossRefPubMed

50.

Lyons MK, Kelly PJ (1991) Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28:659–664PubMed

51.

Mannoji H, Becker LE (1988) Ependymal and choroid plexus tumours. Cytokeratin and GFAP expression. Cancer 61:1377–1385PubMed

52.

Mason WP, Goldman S, Yates AJ, Boyett J, Li H, Finlay JL (1998) Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma—a report of the Children's Cancer Group [see comments]. J Neurooncol 37:135–143CrossRefPubMed

53.

Mathews T, Moossy J (1974) Gliomas containing bone and cartilage. J Neuropathol Exp Neurol 33:456–471PubMed

54.

Mazewski C, Soukup S, Ballard E (1999) Karyotype studies in 18 ependymomas with literature review of 107 cases. Cancer Genet Cytogenet 113:1–8CrossRefPubMed

55.

McLaughlin MP, Marcus RB Jr, Buatti JM, McCollough WM, Mickle JP, Kedar A, Maria BL, Million RR (1998) Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys 40:845–850CrossRefPubMed

56.

Min KW, Scheithauer BW (1997) Clear cell ependymoma: a mimic of oligodendroglioma: clinicopathologic and ultrastructural considerations. Am J Surg Pathol 21:820–826CrossRefPubMed

57.

Morantz RA, Kepes JJ, Batnitzky S, Masterson BJ (1979) Extraspinal ependymomas. Report of three cases. J Neurosurg 51:383–391PubMed

58.

Mork SJ, Loken AC (1977) Ependymoma: a follow-up study of 101 cases. Cancer 40:907–915PubMed

59.

Murakami M, Kuratsu J, Takeshima H, Soyama N, Shinojima N, Ushio Y (2000) Spinal seeding of anaplastic ependymoma mimicking fungal meningitis. A case report and review of the literature. J Neurosurg Sci 44:46–52PubMed

60.

Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB (1990) Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72:408–417PubMed

61.

Needle MN, Goldwein JW, Grass J, Cnaan A, Bergman I, Molloy P et al (1997) Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 80:341–347CrossRefPubMed

62.

Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K (1993) Cytogenetic analysis of 109 pediatric central nervous system tumours. Cancer Genet Cytogenet 71:40–49PubMed

63.

Nijssen PC, Deprez RH, Tijssen CC, et al (1994) Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. J Neurol Neurosurg Psychiatry 57:1245–1248PubMed

64.

Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P (1991) p53 mutations in nonastrocytic human brain tumours. Cancer Res 51:6202–6205PubMed

65.

Okamoto M, Sasaki M, Suzio K et al (1988) Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature 331:273–277PubMed

66.

Olivecrona H (1967) The surgical treatment of intracranial tumours. In: Olivecrona H (ed) Handbook of neurosurgery, vol 4

67.

Palma L, Celli P, Cantore G (1993) Supratentorial ependymomas of the first two decades of life. Long-term follow-up of 20 cases (including two subependymomas). Neurosurgery 32:169–175PubMed

68.

Palma L, Celli P, Mariottini A, Zalaffi A, Schettini G (2000) The importance of surgery in supratentorial ependymomas: long-term survival in a series of 23 cases. Childs Nerv Syst 16:170–175CrossRefPubMed

69.

Perilongo G, Massimino M, Sotti G, Belfontali T, Masiero L, Rigobello L, et al (1997) Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 29:79–85CrossRefPubMed

70.

Pierre-Kahn A, Hirsch JF, Roux FX, Renier D, Sainte-Rose C (1983) Intracranial ependymomas in childhood. Survival and functional results of 47 cases. Childs Brain 10:145–156PubMed

71.

Pimentel J, Kepes JJ, Moura Nunes JF, Bentes C, Miguens J, Antunes JL (2001) Supratentorial giant cell ependymoma. Clin Neuropathol 20:31–37PubMed

72.

Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M (1995) Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37:655–666PubMed

73.

Prayson RA (1999) Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 3:11–18PubMed

74.

Ransom DT, Ritland SR, Kimmel DW (1992) Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 5:348–356PubMed

75.

Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230–237CrossRefPubMed

76.

Ringertz N, Raymond A (1949) Ependymomas and choroid plexus papillomas. J Neuropathol Exp Neurol 8:355–380

77.

Robertson PL, Zeltzer PM, Boyett JM, et al (1998) Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 88:695–703PubMed

78.

Rogatto SR, Casartelli C, Rainho CA (1993) Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 69:146–152CrossRefPubMed

79.

Rosenblum MK (1998) Ependymal tumours: a review of their diagnostic surgical pathology. Pediatr Neurosurg 28:160–165CrossRefPubMed

80.

Rosenblum MK, Erlandson RA, Aleksic SN, Budzilovich G (1990) Melanotic ependymoma and subependymoma. Am J Surg Pathol 14:729–736PubMed

81.

Ross GW, Rubinstein LJ (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70:31–36

82.

Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, Gusella JF, Louis DN (1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54:45–47PubMed

83.

Ruchoux MM, Kepes JJ, Dhellemmes P, Hamon M, Maurage CA, Lecomte M, Gall CM, Chilton J (1998) Lipomatous differentiation in ependymomas: a report of three cases and comparison with similar changes reported in other central nervous system neoplasms of neuroectodermal origin. Am J Surg Pathol 22:338–346CrossRefPubMed

84.

Sainati L, Montaldi A, Putti MC, Giangaspero F, Rigobello L, Stella M, Zanesco L, Basso G (1992) Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? Cancer Genet Cytogenet 59:213–216

85.

Sara A, Bruner JM, Mackay B (1994) Ultrastructure of ependymoma. Ultrastruct Pathol 18:33–42PubMed

86.

Sato K, Schauble B, Kleihues P, Ohgaki H (1996) Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumours. Int J Cancer 66:305–308PubMed

87.

Sawyer JR, Sammartino G, Husain M (1994) Chromosome aberrations in four ependymomas. Cancer Genet Cytogenet 74:132–138CrossRefPubMed

88.

Schiffer D, Giordana MT (1998) Prognosis of ependymoma. Childs Nerv Syst 14:357–361CrossRefPubMed

89.

Schiffer D, Chio A, Cravioto H, Giordana MT, Migheli A, Soffietti R, Vigliani MC (1991) Ependymoma: internal correlations among pathologic signs and the anaplastic variant. Neurosurgery 29:206–210PubMed

90.

Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A (1991) Histologic prognostic factors in ependymomas. Childs Nerv Syst 7:177–182PubMed

91.

Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chr. 22 in tumorigenesis of acoustic neuroma. Nature 322:644–647PubMed

92.

Smyth MD, Horn BN, Russo C, Berger MS (2000) Intracranial ependymomas of childhood: current management strategies. Pediatr Neurosurg 33:138–150CrossRefPubMed

93.

Sonneland PR, Scheithauer BW, Onofrio BM (1985) Myxopapillary ependymoma: a clinicopathologic and immunocytochemical study of 77 cases. Cancer 56:883–893PubMed

94.

Spagnoli D, Tomei G, Ceccarelli G, Grimoldi N, Lanterna A, Bello L, Sinisi MM, De Santis A, Villani RM (2000) Combined treatment of fourth ventricle ependymomas: report of 26 cases. Surg Neurol 54:19–26CrossRefPubMed

95.

Strother D, Kepner J, Constine LS, Burger P, Langston J, Duffner P, Kun L, Friedman HS, Kupst MJ, Horowitz M (2000) Dose-intensive chemotherapy prolongs event-free survival for very young children with ependymoma. Results of pediatric oncology group study 9233. Proc Am Soc Clin Oncol 19:585

96.

Sutton LN, Goldwein J, Perilongo G, Lang B, Schut L, Rorke L, Packer R (1990–1991) Prognostic factors in childhood ependymomas. Pediatric Neurosurg 16:57–65

97.

Tominaga T, Kayama T, Kumabe T, Sonoda Y, Yoshimoto T (1995) Anaplastic ependymomas: clinical features and tumour suppressor gene p53 analysis. Acta Neurochir 135:163–170

98.

Tomita T, McLone DG, Das L, Brand WN (1988) Benign ependymomas of the posterior fossa in childhood. Pediatr Neurosci 14:277–285PubMed

99.

Tong CY, Zheng PP, Pang JC, Poon WS, Chang AR, Ng HK (2001) Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers. J Neurosurg 95:9–14PubMed

100.

Tong CYK, Ng HK, Pang JCS (1999) Molecular genetic analysis of non-astrocytic gliomas. Histopathology 34:331–341CrossRefPubMed

101.

Vajtai I, Mucsi Z, Varga Z, Bodi I (1999) Signet-ring cell ependymoma: case report with implications for pathogenesis and differential diagnosis. Pathol Res Pract 195:853–858PubMed

102.

Vanuytsel LJ, Bessell EM, Ashely SE, Bloom HJ, Brada M (1992) Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 23:313–319PubMed

103.

Vege KD, Giannini C, Scheithauer BW (2000) The immunophenotype of ependymomas. Appl Immunohistochem Molecul Morphol 8:25–31CrossRef

104.

Vinchon M, Soto-Ares G, Riffaud L, Ruchoux MM, Dhellemmes P (2001) Supratentorial ependymoma in children. Pediatr Neurosurg 34:77–87CrossRefPubMed

105.

Von Haken MS, White EC, Daneshvar-Shyesther L (1996) Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17:37–44CrossRefPubMed

106.

Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DG, Warr T (2001) Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32:59–66CrossRefPubMed

107.

Weggen S, Bayer TA, von Deimling A, Reifenberger G, von Schweinitz D, Wiestler OD, Pietsch T (2000) Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 10:85–92PubMed

108.

Weremowicz S, Kupsky WJ, Morton CC (1992) Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 61:193–196CrossRefPubMed

109.

Wernicke C, Thiel G, Lozanova T (1995) Involvement of chromosome 22 in ependymomas. Cancer Genet Cytogenet 79:173–176CrossRefPubMed

110.

West CR, Bruce DA, Duffner PK (1985) Ependymomas: factors in clinical and diagnostic staging. Cancer 56:1812–1816PubMed

111.

White L, Kellie S, Gray E, Toogood I, Waters K, Lockwood L et al (1998) Postoperative chemotherapy in children less than 4 years of age with malignant brain tumours: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG). J Pediatr Hematol Oncol 20:125–130CrossRefPubMed

112.

Zec N, De Girolami U, Schofield DE, Scott RM, Anthony DC (1996) Giant cell ependymoma of the filum terminale. A report of two cases. Am J Surg Pathol 20:1091–1101CrossRefPubMed

113.

Zhen HN, Zhang X, Bu XY, Zhang ZW, Huang WJ, Zhang P, Liang JW, Wang XL (1999) Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumours. Cancer 86:2124–2132CrossRefPubMed

114.

Zuppan CW, Mierau GW, Weeks DA (1994) Ependymoma with signet-ring cells. Ultrastruct Pathol 18:43–46PubMed

Titel: Ependymoma
verfasst von: Charles Teo
Peter Nakaji
Patricia Symons
Vivienne Tobias
Richard Cohn
Robert Smee
Publikationsdatum: 01.06.2003
Verlag: Springer-Verlag
Erschienen in: Child's Nervous System / Ausgabe 5-6/2003
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-003-0753-x

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Introduction

Review

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5-6/2003

Therapeutic strategies and management of desmoplastic infantile ganglioglioma: two case reports and literature overview

Pilocytic astrocytomas with leptomeningeal dissemination: biological behavior, clinical course, and therapeutical options

Endoscopic third ventriculostomy in tuberculous meningitis

Multiple coexistent dysraphic pathologies

Desmoplastic infantile ganglioglioma

A critical analysis of 'normal' radionucleotide shuntograms in patients subsequently requiring surgery

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“